Organization
Korea Otsuka Pharmaceutical
3 clinical trials
Clinical trial
Post-Marketing Surveillance of Safety and Effectiveness of Iclusig® Tablets in Korean Patients With CML or Ph+ ALL Under the "Risk Management Plan"Status: Active (not recruiting), Estimated PCD: 2022-11-29
Clinical trial
Post-Marketing Surveillance(PMS) of Safety and Efficacy of Samsca® Tablets in Korean Patients With ADPKDStatus: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab. in Korean Patients With Acute or Chronic Gastritis in Accordance With Korean Regulation, 'Standard for Re-examination of New Drugs'Status: Recruiting, Estimated PCD: 2024-12-15